Nanobiotix News and Activities

Nanobiotix is one of the...

• CAC All-Trade;
• SBF 120;
• TOB Iconic 10,000.

Nanobiotix is a company listed under the stock ticker NANO (FR).

View the org chart displaying its 18 main executives

Most searched biographies at Nanobiotix

• Laurent Levy, Chief Executive Officer
• Gary Phillips, Chairman of the Board
• Alain Herrera, Director

Create your alert
to follow the executive moves at Nanobiotix.

Nanobiotix has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Nanobiotix

• Press Releases | Nanobiotix
• Voting Rights and Shares Capital of the Company | Nanobiotix
• NANOBIOTIX to Announce Third Quarter 2023 Operational and Financial Update on November 13, 2023 | Nanobiotix
• NANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6M
• NANOBIOTIX Announces Closing of Global Offering | Nanobiotix
• NANOBIOTIX to Present at the H.C. Wainwright 25th Annual Global Investment Conference | Nanobiotix
• NANOBIOTIX Strengthens Global Development Capabilities With the Appointment of Veteran Industry Leader Dr. Louis Kayitalire as Chief Medical Officer | Nanobiotix
• NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3 | Nanobiotix
• NANOBIOTIX to Host Extraordinary General Meeting of Shareholders on September 1st, 2023 | Nanobiotix
• Voting Rights and Shares Capital of the Company | Nanobiotix S.A.
• View more press releases Close

Social media about Nanobiotix

• Nanobiotix on Wikipedia, Google News & Yahoo Finance
• Nanobiotix on LinkedIn, X (Twitter) & YouTube